Back to top

Aclarion announces first patient enrolled in Clarity trial

Aclarion (ACON) announced the first patient enrollment in the Clarity trial evaluating Nociscan’s clinical and economic value in spine surgery. The...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Aclarion, Inc. (ACON)